Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05102214
Title HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Shanghai Henlius Biotech

transitional cell carcinoma

gastroesophageal junction adenocarcinoma

head and neck squamous cell carcinoma

Advanced Solid Tumor

gastric adenocarcinoma

lung non-small cell carcinoma



Age Groups: senior | adult
Covered Countries

No variant requirements are available.